O	0	9	Vasomotor
O	10	18	symptoms
O	18	19	,
O	20	28	adoption
O	29	31	of
O	32	33	a
B-intervention	34	37	low
I-intervention	37	38	-
I-intervention	38	41	fat
I-intervention	42	49	dietary
I-intervention	50	57	pattern
O	57	58	,
O	59	62	and
O	63	67	risk
O	68	70	of
O	71	79	invasive
O	80	86	breast
O	87	93	cancer
O	93	94	:
O	95	96	a
O	97	106	secondary
O	107	115	analysis
O	116	118	of
O	119	122	the
O	123	128	Women
O	128	129	'
O	129	130	s
O	131	137	Health
O	138	148	Initiative
O	149	159	randomized
O	160	170	controlled
O	171	178	dietary
O	179	191	modification
O	192	197	trial
O	197	198	.

O	199	201	To
O	202	208	assess
O	209	216	whether
O	217	220	the
O	221	227	effect
O	228	230	of
O	231	232	a
O	233	236	low
O	236	237	-
O	237	240	fat
O	241	248	dietary
O	249	256	pattern
O	257	259	on
O	260	266	breast
O	267	273	cancer
O	274	283	incidence
O	284	290	varied
O	291	293	by
O	294	300	report
O	301	303	of
O	304	312	baseline
O	313	322	vasomotor
O	323	331	symptoms
O	331	332	.

O	333	347	Postmenopausal
O	348	353	women
O	354	357	age
B-age	358	360	50
I-age	361	363	to
I-age	364	366	79
I-age	367	372	years
O	373	381	enrolled
O	382	386	onto
O	387	390	the
O	391	396	Women
O	396	397	'
O	397	398	s
O	399	405	Health
O	406	416	Initiative
O	417	418	(
O	418	421	WHI
O	421	422	)
O	423	430	Dietary
O	431	443	Modification
O	444	449	trial
O	450	454	from
O	455	459	1993
O	460	462	to
O	463	467	1998
O	468	472	were
O	473	481	randomly
O	482	490	assigned
O	491	493	to
O	494	495	a
O	496	499	low
O	499	500	-
O	500	503	fat
O	504	511	dietary
O	512	524	intervention
O	525	526	(
O	526	527	n
O	528	529	=
B-intervention-participants	530	532	19
I-intervention-participants	532	533	,
I-intervention-participants	533	536	541
O	536	537	)
O	538	540	or
B-control	541	551	comparison
O	552	553	(
O	553	554	n
O	555	556	=
B-control-participants	557	559	29
I-control-participants	559	560	,
I-control-participants	560	563	294
O	563	564	)
O	564	565	.

O	566	574	Presence
O	575	577	of
O	578	587	vasomotor
O	588	596	symptoms
O	597	599	at
O	600	608	baseline
O	609	612	was
O	613	624	ascertained
O	625	629	from
O	630	631	a
O	632	634	34
O	634	635	-
O	635	639	item
O	640	644	self
O	644	645	-
O	645	651	report
O	652	659	symptom
O	660	669	inventory
O	669	670	.

O	671	676	Women
O	677	681	were
O	682	689	queried
O	690	694	semi
O	694	695	-
O	695	703	annually
O	704	707	for
O	708	709	a
O	710	713	new
O	714	723	diagnosis
O	724	726	of
O	727	733	breast
O	734	740	cancer
O	740	741	.

O	742	746	Each
O	747	751	case
O	752	758	report
O	759	762	was
O	763	771	verified
O	772	774	by
O	775	782	medical
O	783	789	record
O	790	793	and
O	794	803	pathology
O	804	810	report
O	811	817	review
O	818	820	by
O	821	830	centrally
O	831	838	trained
O	839	842	WHI
O	843	852	physician
O	853	865	adjudicators
O	865	866	.

O	867	872	Among
O	873	885	participants
O	886	889	who
O	890	898	reported
O	899	902	hot
O	903	910	flashes
O	911	912	(
O	912	915	HFs
O	915	916	)
O	917	919	at
O	920	928	baseline
O	929	930	(
O	930	931	n
O	932	933	=
O	934	935	3
O	935	936	,
O	936	939	375
O	939	940	)
O	940	941	,
O	942	947	those
O	948	956	assigned
O	957	959	to
O	960	963	the
O	964	967	low
O	967	968	-
O	968	971	fat
O	972	976	diet
O	977	980	had
O	981	982	a
B-outcome	983	989	breast
I-outcome	990	996	cancer
I-outcome	997	1001	rate
O	1002	1004	of
B-iv-bin-percent	1005	1006	0
I-iv-bin-percent	1006	1007	.
I-iv-bin-percent	1007	1009	27
O	1010	1018	compared
O	1019	1023	with
O	1024	1029	their
O	1030	1042	counterparts
O	1043	1045	in
O	1046	1049	the
O	1050	1057	control
O	1058	1063	group
O	1064	1067	who
O	1068	1071	had
O	1072	1073	a
O	1074	1078	rate
O	1079	1081	of
B-cv-bin-percent	1082	1083	0
I-cv-bin-percent	1083	1084	.
I-cv-bin-percent	1084	1086	41
O	1087	1088	(
O	1088	1094	hazard
O	1095	1100	ratio
O	1101	1102	[
O	1102	1104	HR
O	1104	1105	]
O	1106	1107	=
O	1108	1109	0
O	1109	1110	.
O	1110	1112	65
O	1112	1113	;
O	1114	1116	95
O	1116	1117	%
O	1118	1120	CI
O	1120	1121	,
O	1122	1123	0
O	1123	1124	.
O	1124	1126	42
O	1127	1129	to
O	1130	1131	1
O	1131	1132	.
O	1132	1134	01
O	1134	1135	)
O	1135	1136	.

O	1137	1142	Among
O	1143	1148	women
O	1149	1158	reporting
O	1159	1161	no
O	1162	1165	HFs
O	1166	1167	(
O	1167	1168	n
O	1169	1170	=
O	1171	1173	45
O	1173	1174	,
O	1174	1177	160
O	1177	1178	)
O	1178	1179	,
O	1180	1183	the
B-outcome	1184	1190	breast
I-outcome	1191	1197	cancer
I-outcome	1198	1202	rate
O	1203	1206	was
B-iv-bin-percent	1207	1208	0
I-iv-bin-percent	1208	1209	.
I-iv-bin-percent	1209	1211	42
O	1212	1214	in
O	1215	1220	those
O	1221	1229	assigned
O	1230	1232	to
O	1233	1236	the
O	1237	1240	low
O	1240	1241	-
O	1241	1244	fat
O	1245	1249	diet
O	1250	1258	compared
O	1259	1263	with
B-cv-bin-percent	1264	1265	0
I-cv-bin-percent	1265	1266	.
I-cv-bin-percent	1266	1268	46
O	1269	1271	in
O	1272	1275	the
O	1276	1283	control
O	1284	1289	group
O	1290	1291	(
O	1291	1293	HR
O	1294	1295	=
O	1296	1297	0
O	1297	1298	.
O	1298	1300	93
O	1300	1301	;
O	1302	1304	95
O	1304	1305	%
O	1306	1308	CI
O	1308	1309	,
O	1310	1311	0
O	1311	1312	.
O	1312	1314	84
O	1315	1317	to
O	1318	1319	1
O	1319	1320	.
O	1320	1322	03
O	1322	1323	;
O	1324	1325	P
O	1326	1329	for
O	1330	1341	interaction
O	1342	1343	=
O	1344	1345	.
O	1345	1347	12
O	1348	1350	by
O	1351	1353	HF
O	1354	1360	status
O	1360	1361	)
O	1361	1362	.

O	1363	1374	Furthermore
O	1374	1375	,
O	1376	1379	the
O	1380	1387	dietary
O	1388	1396	benefits
O	1397	1405	observed
O	1406	1412	seemed
O	1413	1415	to
O	1416	1418	be
O	1419	1427	specific
O	1428	1430	to
O	1431	1439	estrogen
O	1440	1448	receptor
O	1449	1450	(
O	1450	1452	ER
O	1452	1453	)
O	1454	1455	-
O	1455	1463	positive
O	1463	1464	/
O	1464	1476	progesterone
O	1477	1485	receptor
O	1486	1487	(
O	1487	1489	PR
O	1489	1490	)
O	1491	1492	-
O	1492	1500	positive
O	1501	1507	tumors
O	1508	1509	(
O	1509	1511	ER
O	1512	1520	positive
O	1520	1521	/
O	1521	1523	PR
O	1524	1532	positive
O	1533	1534	v
O	1535	1540	other
O	1540	1541	,
O	1542	1543	P
O	1544	1547	for
O	1548	1552	risk
O	1553	1554	=
O	1555	1556	.
O	1556	1558	03
O	1558	1559	)
O	1559	1560	.

O	1561	1569	Although
O	1570	1575	women
O	1576	1580	with
O	1581	1584	and
O	1585	1592	without
O	1593	1596	HFs
O	1597	1605	differed
O	1606	1610	with
O	1611	1617	regard
O	1618	1620	to
O	1621	1627	breast
O	1628	1634	cancer
O	1635	1639	risk
O	1640	1647	factors
O	1647	1648	,
O	1649	1652	the
O	1653	1659	effect
O	1660	1662	of
O	1663	1666	the
O	1667	1671	diet
O	1672	1684	intervention
O	1685	1687	on
B-outcome	1688	1694	breast
I-outcome	1695	1701	cancer
I-outcome	1702	1711	incidence
O	1712	1714	by
O	1715	1717	HF
O	1718	1724	status
O	1725	1728	was
O	1729	1739	consistent
O	1740	1746	across
O	1747	1751	risk
O	1752	1758	factor
O	1759	1765	strata
O	1765	1766	.

O	1767	1770	The
O	1771	1778	results
O	1779	1781	of
O	1782	1786	this
O	1787	1792	trial
O	1792	1793	,
O	1794	1799	which
O	1800	1803	are
O	1804	1814	hypothesis
O	1815	1825	generating
O	1825	1826	,
O	1827	1834	suggest
O	1835	1839	that
O	1840	1843	HFs
O	1844	1847	may
O	1848	1856	identify
O	1857	1858	a
O	1859	1867	subgroup
O	1868	1870	of
O	1871	1885	postmenopausal
O	1886	1891	women
O	1892	1897	whose
O	1898	1902	risk
O	1903	1905	of
O	1906	1914	invasive
O	1915	1921	breast
O	1922	1928	cancer
O	1929	1934	might
O	1935	1937	be
O	1938	1945	reduced
O	1946	1950	with
O	1951	1954	the
O	1955	1963	adoption
O	1964	1966	of
O	1967	1968	a
O	1969	1972	low
O	1972	1973	-
O	1973	1976	fat
O	1977	1983	eating
O	1984	1991	pattern
O	1991	1992	.
